IHS Chemical Week

People & Business :: Earnings/Finance

DSM reports lower sales, earnings on negative currency effects, weakness in caprolactam

8:14 AM MDT | August 5, 2014 | Natasha Alperowicz

DSM today reported second-quarter net profit from continuing operations before exceptional items of €110 million ($147.6 million), 20% down on the year-earlier quarter. Revenues from continuing operations were flat, €2.29 billion, and Ebitda was 12% lower, €293 million. The nutrition segment's revenues dropped 3%, to €1.07 billion, and Ebitda was 11% down, at €222 million. The performance materials business recorded sales of €702 million, 1% down on the second quarter of 2013, and a 10% rise in Ebitda, to €88 million. Polymer...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa